Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, O and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The disclosure discloses a method and device for processing a Service Function Chaining (SFC). The method includes that: the SFC receives a message sent from forwarding equipment; the SFC generates a forwarding table corresponding to the message; and under a condition that a preset state of a forwarding table sending switch is on, the SFC sends the forwarding table to the forwarding equipment to make the forwarding equipment forward the message according to the forwarding table when receiving the message, wherein the forwarding table sending switch is used for indicating the SFC whether to send the forwarding table to the forwarding equipment or not. By the disclosure, an effect of increasing a success rate of data forwarding of the SFC is achieved.

Abstract: Provided are a method, apparatus and a cloud detection system for detecting a network device. The method includes that a detection packet library is created based on characteristic information and service configuration of a network device; characteristic information and service configuration of a to-be-detected network device are acquired; a detection packet is matched in the detection packet library according to the acquired characteristic information and service configuration of the to-be-detected network device, and the to-be-detected network device is detected by using the matched detection packet.

Abstract: A method and device for implementing a Service Function Chain (SFC) are provided. The method is applied to a node on the SFC, and the method includes that: SFC information is encapsulated in an Internet Protocol version 6 (IPv6) of an IPv6 packet; and the IPv6 packet is sent according to the SFC information. After the IPv6 packet containing the SFC information is received, the SFC information is parsed; and an IPv6 address of a next-hop node of a Service Function Path (SFP) is acquired as a destination address, and the IPv6 packet is sent to the destination address.

Abstract: The present disclosure provides a packet transmission method and apparatus. The method includes: a classifier receiving a first packet; the classifier determining a first service function (SF) to which the first packet is to be transmitted; the classifier adding an address of the first SF to the first packet, obtaining a second packet; and the classifier transmitting the second packet to a network virtualization edge (NVE) node.

Abstract: A transformer system includes: a main transformer including a primary winding coupled to AC mains and a secondary winding; a load circuit including a load switch configured to be coupled to a load, the load circuit being coupled to the secondary winding of the main transformer; an auxiliary power supply coupled to AC mains; a controller coupled to an output of the auxiliary power supply; an electronic switch between the AC mains and the primary winding of the main transformer and configured to be controlled by the controller; and a load detector coupled to the load circuit and configured to detect whether the load is connected to the main transformer and to output a load signal to the controller in accordance with whether or not the load is connected to the main transformer, wherein the controller is configured to control the electronic switch in accordance with the load signal.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: This document discloses methods and apparatuses for sending, transferring and acquiring a capability. Herein, one or more PCP servers send their own PCP server capability indices to a bearer protocol server, and the bearer protocol server sends the corresponding capability information to a PCP client, and the PCP client selects an appropriate PCP server to be connected according to the capability information.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: A semiconductor device has a semiconductor die and encapsulant deposited over the semiconductor die. A first insulating layer is formed over the die and encapsulant. The first insulating layer is cured with multiple dwell cycles to enhance adhesion to the die and encapsulant. A first conductive layer is formed over the first insulating layer. A second insulating layer is formed over the first insulating layer and first conductive layer. The second insulating layer is cured with multiple dwell cycles to enhance adhesion to the first insulating layer and first conductive layer. A second conductive layer is formed over the second insulating layer and first conductive layer. A third insulating layer is formed over the second insulating layer and second conductive layer. The first, second, and third insulating layers have different CTE. The second insulating layer or third insulating layer is cured to a dense state to block moisture.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: Disclosed are a method, device, and computer storage medium for implementing IP address advertisement. An advertisement for controlling LSA11 and an advertisement control switch for flooding are added into a router. The router performs, according to a state indicated by the advertisement control switch, IP address advertisement or flooding for LSA11 encapsulated with an IP address.

Abstract: Wastewater treatment methods and systems for removal of phosphorus (P) and nitrogen (N) from wastewater and for recovery of them as usable materials. Sufficient amount of dolomite lime and slaked dolomite lime is added into the wastewater to increase the pH of the wastewater to above 8.5 and to form P precipitates and to convert ammonium to ammonia in a precipitation-ammonia stripping reactor or a continuous flow precipitation reactor. The P precipitates are separated from the wastewater and recovered as usable solid material. The ammonia gas is absorbed and concentrated with acid solution in an ammonia absorption tower as usable liquid material.

Abstract: A flexible polymeric dielectric layer has first and second major surfaces. The first major surface has a conductive layer thereon. The dielectric layer has at least one cavity extending from the second major surface toward the first major surface. The conductive layer includes electrically separated first and second portions configured to support and electrically connect a light emitting semiconductor device to the conductive layer.

Abstract: A transformer system includes: a main transformer including a primary winding coupled to AC mains and a secondary winding; a load circuit including a load switch configured to be coupled to a load, the load circuit being coupled to the secondary winding of the main transformer; an auxiliary power supply coupled to AC mains; a controller coupled to an output of the auxiliary power supply; an electronic switch between the AC mains and the primary winding of the main transformer and configured to be controlled by the controller; and a load detector coupled to the load circuit and configured to detect whether the load is connected to the main transformer and to output a load signal to the controller in accordance with whether or not the load is connected to the main transformer, wherein the controller is configured to control the electronic switch in accordance with the load signal.

Abstract: The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.